20
Participants
Start Date
June 26, 2016
Primary Completion Date
April 7, 2017
Study Completion Date
April 7, 2017
Aspirin
The intervention has been described previously in both arms individually. Group A will receive 20mg of soluble Aspirin and group B with 75mg of soluble Aspirin. As this is a crossover study, all patients will fall under both groups throughout the duration and be un-blinded.
Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield
Sheffield Teaching Hospitals NHS Foundation Trust
OTHER